市场调查报告书
商品编码
1494627
普通手术器械市场:按类型、应用和最终用途分类 - 2024-2030 年全球预测General Surgery Devices Market by Type (Adhesion Prevention Products, Disposable Surgical Supplies, Energy-based & Powered Instrument), Application (Audiology, Cardiology, Neurosurgery), End-use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年普通手术器械市场规模为178.4亿美元,预计2024年将达到189.4亿美元,2030年将达280.4亿美元,复合年增长率为6.67%。
一般外科器械是指专门设计用于辅助一般外科手术和程序的仪器和工具。这些器械包括各种工具,例如手术刀、镊子、剪刀和缝线。此类别还包括更先进的器械,例如使用电能进行切割和止血的电外科器械,以及用于闭合伤口和切口的缝合器械。需要手术介入的慢性疾病的盛行率不断上升,加上人口老化的加剧,主要推动了市场的发展。此外,开发中国家医疗保健基础设施的改善和扩大为引进先进手术设备提供了机会。然而,先进手术设备的高成本可能是一个主要障碍,特别是在欠开发中地区。有关医疗设备核准的严格规定可能会延迟产品上市并增加开发成本。此外,对能够减少手术侵入性、缩短恢復时间并併发症减少併发症的设备的需求不断增长。利用人工智慧和物联网提高手术精度和效率的智慧手术设备的开拓为市场带来了重大机会。
主要市场统计 | |
---|---|
基准年[2023] | 178.4亿美元 |
预测年份 [2024] | 189.4亿美元 |
预测年份 [2030] | 280.4亿美元 |
复合年增长率(%) | 6.67% |
区域洞察
由于先进的医疗基础设施、高昂的医疗成本和不断的创新,美洲地区普通外科设备的采用率很高。微创手术的显着趋势需要精密、复杂的手术器械和设备。美国食品药物管理局(FDA) 在监管和核准新设备、确保其安全性和有效性方面发挥重要作用。加拿大共用了这个趋势,两国政府都积极投资于医疗保健技术研究。欧洲国家受益于完善的医疗保健系统和欧洲药品管理局 (EMA) 的统一监管。欧洲的需求是由人口老化和高标准的外科护理所推动的。在中东,海湾国家拥有现代化的医疗设施,并大力投资医疗旅游业,而许多非洲国家则急需基本的外科和医疗基础设施。亚太地区的特点是经济快速成长、医疗支出增加和公共卫生意识增强。中国和印度的中产阶级不断壮大,卫生政策不断改革,一般外科设备具有巨大的市场潜力。日本以其技术力而闻名,在高端设备製造和创新手术技术方面处于领先地位。
FPNV定位矩阵
FPNV 定位矩阵对于评估通用手术器械市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对普通手术器械市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在普通手术器械市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[198 Pages Report] The General Surgery Devices Market size was estimated at USD 17.84 billion in 2023 and expected to reach USD 18.94 billion in 2024, at a CAGR 6.67% to reach USD 28.04 billion by 2030.
General surgery devices refer to a range of instruments and tools specifically designed to assist with operations and procedures commonly performed during general surgery. These devices can include a variety of tools such as scalpels, forceps, scissors, and sutures. Additionally, more advanced equipment, including electrosurgical devices, which use electrical energy to cut or control bleeding, and staple devices, which are used to close wounds or incisions, are considered part of this category. The growth in the prevalence of chronic diseases that require surgical intervention, coupled with a growing aging population, is primarily pushing the market forward. Additionally, improvements and expansions in healthcare infrastructure in developing countries present opportunities for the adoption of advanced surgical devices. However, the high cost of advanced surgical devices can be a significant hindrance, particularly in less developed regions. Stringent regulations governing the approval of medical devices can delay product launches and increase development costs. Furthermore, growing demand for devices that make surgeries less invasive, reduce recovery time, and minimize complications. The development of smart surgical devices that use artificial intelligence and the Internet of Things to offer enhanced precision and efficiency in surgeries poses significant opportunities to the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 17.84 billion |
Estimated Year [2024] | USD 18.94 billion |
Forecast Year [2030] | USD 28.04 billion |
CAGR (%) | 6.67% |
Regional Insights
In the American region, the adoption of general surgery devices is robust due to advanced healthcare infrastructure, high healthcare expenditure, and a constant push for technological innovations. A notable trend towards minimally invasive surgeries demands precise and sophisticated surgical instruments and devices. The U.S. Food and Drug Administration (FDA) plays a crucial role in regulating and approving new devices, ensuring safety and efficacy. Canada shares these trends, with both governments actively investing in healthcare technology research. European countries benefit from well-established healthcare systems and uniform regulations enforced by the European Medicines Agency (EMA). The demand in Europe is driven by an aging population and a high standard of surgical care. In the Middle East region, the Gulf states have modern medical facilities and are investing heavily in medical tourism, whereas many African countries are in urgent need of basic surgical and medical infrastructure. The APAC region is marked by rapid economic growth, increasing healthcare expenditure, and growing public health awareness. China and India, with their burgeoning middle classes and reforms in healthcare policies, show significant market potential for general surgery devices. Japan, known for its technological prowess, leads in high-end device manufacturing and innovative surgical techniques.
Market Insights
The market dynamics represent an ever-changing landscape of the General Surgery Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the General Surgery Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the General Surgery Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
FDA Approval Granted to Virtual Incision's MIRA: The First Miniaturized Robotic-Assisted Surgery System for Colectomies
The U.S. Food and Drug Administration (FDA) authorized the MIRA Surgical System, developed by Virtual Incision. This milestone marks MIRA as the first miniaturized, robotic-assisted surgery (RAS) device specifically approved for use in adult colectomy procedures. MIRA's small, self-contained design enables operation directly within the abdominal cavity without requiring a dedicated operating room or creating extensive setup times. [Published On: 2024-02-24]
RTI Surgical Expands Portfolio with Strategic Acquisition of Cook Biotech
RTI Surgical has officially announced its acquisition of Cook Biotech, a division of Cook Group specializing in biologic grafts. This strategic move aims to enhance RTI Surgical's product offerings and fortify its position in the global surgical devices market. Cook Biotech is renowned for its innovative technologies in regenerative medicine, and its integration under RTI Surgical's umbrella is expected to extend RTI's capabilities in biologic grafts and broaden its influence and reach in the healthcare sector. [Published On: 2024-01-08]
Johnson & Johnson MedTech Announces Launch Schedule for Innovative General Surgery Robot
Johnson & Johnson MedTech has outlined significant details and a launch timeline for its new general surgery robot, marking a pivotal step in advancing surgical technologies. This innovative robotic system is designed to enhance precision in various surgical procedures, thereby potentially improving patient outcomes. [Published On: 2023-11-07]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the General Surgery Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the General Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, and Company, Cardinal Health, Inc., Carl Zeiss Meditec AG, CooperSurgical, Inc., Delta Med S.p.A., Ecolab Inc., Globus Medical, Inc., Henry Schein, Inc., Innomed, Inc., Johnson & Johnson Services Inc, Koninklijke Philips N.V., Medica Europe B.V., Medtronic PLC, Olympus Corporation, Schott AG, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage